Nexalin Technology, Inc. (NASDAQ: NXL) had its "hold" rating re-affirmed by analysts at Maxim Group.
New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market [Yahoo! Finance]
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market
Nexalin Technology CEO Provides Letter to Shareholders
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? [Yahoo! Finance]